- Lobbying
- Kevin AND Brennan
Lobbying Arrangements Results for 'Kevin Brennan'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Seek congressional support for Medicare coverage for anti-obesity drugs. |
Orexigen Therapeutics, Inc.
|
FaegreBD Consulting | |||
Details Access to care for individuals with asthma and allergies. |
Allergy & Asthma Network
|
FaegreBD Consulting | |||
Details Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (Pub.L. 112-144). FDA regulation of medical devices. |
Intuitive Surgical, Inc.
|
FOLEY HOAG LLP | |||
Details Issues Related to FDA regulation of needle-free jet administration of vaccines. |
PharmaJet
|
FOLEY HOAG LLP | |||
Details FY14 Labor and Health and Human Services Appropriations bill; promotion of 2007 NIH Expert Panel Guidelines for the Diagnosis and Management of Asthma. |
Thermo Fisher Scientific
|
FOLEY HOAG LLP | |||
Details H.R. 1458/S. 723, Access to Prescription Digital Therapeutics Act of 2023. Legislation to establish Medicare and Medicaid coverage for prescription digital therapeutics. |
Click Therapeutics, Inc.
|
BLUEBIRD STRATEGIES | |||
Details Patient Protection and Affordable Care Act (P.L. 111-148) Health Care and Education Reconciliation Act (P.L. 111-152)(Delivery System Reforms) Budget Control Act of 2011 (P.L. 112-25) |
Onyx Pharmaceuticals
|
FOLEY HOAG LLP | |||
Details Patient Protection and Affordable Care Act (P.L. 111-148) Health Care and Education Reconciliation Act (P.L. 111-152) |
Celgene Corporation
|
FOLEY HOAG LLP | |||
Details H.R. 1458/S. 723, Access to Prescription Digital Therapeutics Act of 2023. Legislation to establish Medicare and Medicaid coverage for prescription digital therapeutics. |
Luminopia, Inc.
|
BLUEBIRD STRATEGIES | |||
Details H.R. 1458/S. 723, Access to Prescription Digital Therapeutics Act of 2023. Legislation to establish Medicare and Medicaid coverage for prescription digital therapeutics. |
MindMaze Inc.
|
BLUEBIRD STRATEGIES | |||
Details H.R. 307, Pandemic and All Hazards Preparedness Reauthorization Act; and Implementation of Project BioShield Act. Implementation of the American Taxpayer Relief Act of 2012 Pub.L. 112240, H.R. 8 S.... |
Chimerix, Inc.
|
FOLEY HOAG LLP | |||
Details Legislation to establish Medicare and Medicaid coverage for prescription digital therapeutics. Medicare/Medicaid coverage report language. Mental health prescription digital therapeutics coverage. |
Pear Therapeutics
|
BLUEBIRD STRATEGIES | |||
Details H.R. 1458/S. 723, Access to Prescription Digital Therapeutics Act of 2023. Legislation to establish Medicare and Medicaid coverage for prescription digital therapeutics. |
Boehringer Ingelheim USA Corporation
|
BLUEBIRD STRATEGIES | |||
Details Federal funding for NIH research. |
Global Down Syndrome Foundation
|
BLUEBIRD STRATEGIES | |||
Details Legislative and regulatory matters related to the FDA and CMS with focus on the coverage and reimbursement of novel therapeutics for the treatment of obesity |
Orexigen Therapeutics, Inc.
|
in-house lobbying | |||
Details PL 113-93 (H.R. 4302) - Protecting Access to Medicare Act of 2014; Implementation of changes to Medicare payment for clinical laboratory tests. Draft legislation to regulate clinical labs under CLI... |
Myriad Genetics, Inc.
|
Faegre Baker Daniels Consulting | |||
Details Increasing funding for Myotonic Dystrophy research. Fiscal Year 2024 defense appropriations legislation. Peer Review Medical Research Program and Congressional Directed Medical Research Program. Fe... |
Myotonic
|
BLUEBIRD STRATEGIES | |||
Details Opposition to prescription drug importation legislation |
Alliance for Safe Online Pharmacies (ASOP)
|
Faegre Baker Daniels Consulting (f/k/a FaegreBD Consulting) | |||
Details Increase awareness of clinical use of FDA cleared prescription digital therapeutics. Medicare coverage of FDA cleared prescription digital therapeutics. |
Pear Therapeutics
|
Faegre Baker Daniels Consulting | |||
Details H.R. 1458/S. 723, Access to Prescription Digital Therapeutics Act of 2023. Legislation to establish Medicare and Medicaid coverage for prescription digital therapeutics. |
Otsuka America Pharmaceutical, Inc.
|
BLUEBIRD STRATEGIES | |||
Details CDC Infection Disease Public Health & Epidemiology Funding. Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization. Pioneering Antimicrobial Subscriptions to End Upsurging Resistance PAS... |
The Peggy Lillis Foundation
|
BLUEBIRD STRATEGIES | |||
Details Legislation to regulate clinical labs under CLIA and FDA. Medicaid coverage for mental health genetic testing. VA access for mental health genetic testing. Medicaid precision medicine legislation. |
Myriad Genetics, Inc.
|
BLUEBIRD STRATEGIES | |||
Details S. 3187 Food and Drug Administration Safety and Administration Act H.R. 5651 Food and Drug Administration Reform Act Work to educate Congress on telehealth and telemedicine issues in the Prescripti... |
Teladoc, Inc.
|
FOLEY HOAG LLP | |||
Details MODDERN Cures Act, H.R. 3091 and H.R. 3116. |
Eli Lilly and Company
|
FOLEY HOAG LLP | |||
Details Federal funding for NIH research. |
Faegre Baker Daniels Consulting (on behalf of Global Down Syndrome Foundation)
|
BLUEBIRD STRATEGIES | |||
Details -H.R.7667, S.4348, reauthorization of FDA user fees -Implementation of the Orphan Drug Act of 1983 (P.L. 97-414) and orphan drug development -Implementation of the FDA Reauthorization Act (P.L. 11... |
Horizon Therapeutics USA (formerly Horizon Pharma)
|
FOLEY HOAG LLP | |||
Details Medicare drug reimbursement |
Optimer Pharmaceuticals, Inc.
Pharmaceutical company |
FOLEY HOAG LLP | |||
Details -Medicare payment and coverage for clinical laboratory tests. |
Myriad Genetic Laboratories, Inc.
|
Foley Hoag, LLP | |||
Details Issues related to the Medical Device User Fee Program and to FDA regulated medical devices; issues related to the Regulation & Reimbursement of Diagnostics, regarding all provisions. Issues relate... |
Johnson and Johnson Services, Inc.
|
FOLEY HOAG LLP | |||
Details Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act (P.L. 111-152) Medicare Orthotics and Prosthetics Improvement Act (H.R.1958); Insurance Fairn... |
American Orthotic & Prosthetic Association
|
FOLEY HOAG LLP | |||
Details Increase federal support for research on child abuse and neglect Appropriations for research on child abuse and neglect Enhancing federal funding for research on child abuse and neglect |
Kempe Foundation
|
Faegre Baker Daniels Consulting | |||
Details Colorectal Cancer Medicare and Reimbursement Issues; Screen Act--S. 1511 Supporting Colorectal Examination Now Act; Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148); Health Ca... |
American College of Gastroenterology
|
FOLEY HOAG LLP | |||
Details Drug shortages Asthma policies and diagnostic allergy test coverage; Removing Barriers to Allergy Diagnostics Testing Act of 2019 Fiscal Year 2019 labor HHS appropriations legislation; issues relat... |
Thermo Fisher Scientific
|
Faegre Baker Daniels Consulting | |||
Details Medicare payment for biologics; Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148) (Delivery reforms) H.R. 1862 Regenerative Medicine Promotion Act of 2011; Budget Control Act of ... |
Organogenesis Inc.
Regenerative medicine company. |
FOLEY HOAG LLP | |||
Details Pending healthcare legislation and potential impact on the biopharmaceutical industry. Ryan White Care Act reauthorization; Hepatitis C policy; PEPFAR reauthorization; HIV/AIDS research, testing an... |
GILEAD SCIENCES, INC
|
FOLEY HOAG LLP | |||
Details Increasing funding for Myotonic Dystrophy research; Fiscal Year 2019 Labor and HHS appropriations. Fiscal Year 2019 Defense appropriations legislation; Peer Review Medical Research Program and Cong... |
Myotonic Dystrophy Foundation
|
Faegre Baker Daniels Consulting | |||
Details Fiscal Year 2021 Labor HHS appropriations for Down Syndrome Research; NIH research funding Medicare/Medicaid legislation to promote quality treatment and coordinated care for people with Down Syndrome |
Global Down Syndrome Foundation
|
Faegre Baker Daniels Consulting | |||
Details Medicare Part D Prescription Drug Benefit; Medicare coverage policy for chronic renal disease; Medicare Part B payment and coverage of dialysis products; Congressional deficit reduction negotiatio... |
AMGEN
|
FOLEY HOAG LLP | |||
Details PL 113-93 (HR 4302) - Protecting Access to Medicare Act of 2014; implementation of changes to Medicare payment for clinical laboratory tests. FDA draft guidance to regulate laboratory developed tes... |
Myriad Genetic Laboratories, Inc.
|
Faegre Baker Daniels Consulting | |||
Details Vaccine policy issues |
NOVAVAX
|
Faegre Baker Daniels Consulting | |||
Details Nuclear Regulatory Commission requirements for beta emitters. |
Spectrum Pharmaceuticals
|
FOLEY HOAG LLP | |||
Details Legislative and regulatory matters related to the Food and Drug Administration (FDA) and the Centers for Medicare and Medicaid Services (CMS) with a focus on the coverage and reimbursement of novel... |
Orexigen Therapeutics, Inc.
|
FOLEY HOAG LLP | |||
Details Matters affecting research, diagnosis, treatment and prevention of breast cancer, including 21st Century Cancer Alert Act Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148); Healt... |
Susan G. Komen For The Cure
Non-for-profit breast cancer patient and survivor advocacy group |
FOLEY HOAG LLP | |||
Details Patent Reform Legislation - S 515, HR 1260 FDA Globalization Act - HR 759 Follow-on biologics - HR1427, HR 1548 Physician Payments Sunshine Act - S 301 ARRA; CER Medicare Improvements for Patients ... |
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
|
FOLEY HOAG LLP | |||
Details Issues related to autonomous vehicle safety and technology. |
Western Digital
|
Arnold & Porter Kaye Scholer LLP | |||
Details Policy issues related to the amusement park industry and the federal response to the COVID-19 pandemic. |
Six Flags
|
Arnold & Porter Kaye Scholer LLP | |||
Details Pioneering Antimicrobial Subscriptions to End Upsurging Resistance PASTEUR Act and issues related to sepsis treatment and antibiotic stewardship. CMS coverage for kidney transplant diagnostics. Iss... |
Thermo Fisher Scientific Inc.
|
BLUEBIRD STRATEGIES | |||
Details Fiscal Year 2020 funding for Alzheimer's disease research and policies to enhance NIH Alzheimer's research. S. 1126 - Concentrating on High-Value Alzheimer's Needs to Get to an End (CHANGE) Act of ... |
USAGAINST ALZHEIMER'S
|
Faegre Baker Daniels Consulting | |||
Details HR 2507 - Newborn Screening Saves Lives Reauthorization Act of 2019; Vaccine policy. Medicare coverage and payment for immune globulin (IG) treatments; Part B reimbursement issues; implementation o... |
Immune Deficiency Foundation
|
Faegre Baker Daniels Consulting | |||
Details S Corporation ESOP issues. Policies and funding for recycling, waste materials, and related infrastructure. |
Recology Inc.
|
VENN STRATEGIES |